View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 400 / Paclitaxel 80 / Bevacizumab 10, Ovarian Carcinoma
Protocol-ID: 3164 V1.0 (Mini), PEMB400/PACL80/BEVA10, ovarian cancerIndication(s)
- Ovarian Tumor; ICD-10 C56
Links
- Pembrolizumab vs placebo plus weekly paclitaxel ± bevacizumab in platinum-resistant recurrent ovarian cancer: Results from the randomized double-blind phase III ENGOT-ov65/KEYNOTE-B96 study [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 26.03.2026